Yongin, South Korea

Cook-Hee Kim

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chong Kun Dang Pharmaceutical Corporation. Active years: 2018.


% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cook-Hee Kim: Innovator in Erythropoietin Purification

Introduction

Cook-Hee Kim is a notable inventor based in Yongin, South Korea. He has made significant contributions to the field of biopharmaceuticals, particularly in the purification of erythropoietin analogs. His innovative methods have the potential to enhance the efficiency and cost-effectiveness of producing these important therapeutic proteins.

Latest Patents

Cook-Hee Kim holds a patent for "Methods for purifying erythropoietin analogs having lower isoelectric point." This invention relates to a method for purifying an erythropoietin analog with a low isoelectric point below 4 by incorporating an N-linked sugar chain of high purity. The method allows for the effective purification of erythropoietin analogs, which are isoforms with increased sialic acid residues, through a three-step chromatographic process. This approach not only shortens the purification time but also reduces costs.

Career Highlights

Cook-Hee Kim is associated with Chong Kun Dang Pharmaceutical Corporation, where he applies his expertise in biopharmaceutical research and development. His work has contributed to advancements in the production of therapeutic proteins, which are crucial for treating various medical conditions.

Collaborations

Some of Cook-Hee Kim's coworkers include Ha-Na Kim and Su-Yon Kim, who collaborate with him in research and development efforts at Chong Kun Dang Pharmaceutical Corporation.

Conclusion

Cook-Hee Kim's innovative methods for purifying erythropoietin analogs represent a significant advancement in biopharmaceutical technology. His contributions are poised to improve the efficiency of therapeutic protein production, benefiting the healthcare industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…